MedPath

An in vitro investigation to assess the osteoanabolic effects of doxycycline in a proteosomal gel form.

Not Applicable
Registration Number
CTRI/2024/07/071118
Lead Sponsor
Dr Vaishnavi Langde self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy dental pulp mesenchymal stem cells procured from healthy non carious extracted tooth.

Exclusion Criteria

NI

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Invitro evaluation of the biological behavior of doxycycline proniosomal gel for their use as bone regenerative material.Timepoint: 1,2and 6 months
Secondary Outcome Measures
NameTimeMethod
1.To evaluate the cytotoxic effect of doxycycline proniosomal gel on pulpal dental stem cells by MTT assay. <br/ ><br>2.To study the osteogenic differentiation potential of doxycycline proniosomal gel in mesenchymal stem cells by alizarin red staining. <br/ ><br>3.To investigate the osteogenic gene expression such as alkaline phosphatase and osteonectin for osteogenic differentiation. <br/ ><br>Timepoint: 1,2 and 6 months
© Copyright 2025. All Rights Reserved by MedPath